Dr. Stegall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Summary
- I am a Transplant surgeon and researcher who has been at Mayo Clinic Rochester since 1998. I have performed more than 2000 kidney transplants.
My major clinical and research interests involve new therapies that improve the outcomes of transplant recipients. Specifically I am interested in overcoming antibody barriers to transplantation, management of obesity and diabetes in Transplant recipients and developing novel immunosuppressive including total withdrawal/tolerance protocols. My group is also interested in computer assisted assessment of Transplant biopsies.
I also am the Director of the Multicenter Transplant Alliance (mtaconsortium.com), a clinical research group aimed at facilitating novel, high-impact clinical trials in transplantation.
Education & Training
University of Wisconsin Hospitals and ClinicsResidency, Surgery, 1991 - 1993
New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 1984 - 1991
Columbia University Vagelos College of Physicians and SurgeonsClass of 1984
Harvard UniversityAB, Biology , Magna cum laude, 1974 - 1979
Certifications & Licensure
MN State Medical License 1998 - 2024
CO State Medical License 1993 - 1999
WI State Medical License 1991 - 1993
NY State Medical License 1986 - 1992- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors Start of enrollment: 2005 Mar 01
- The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients. Start of enrollment: 2005 Dec 01
- The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients Start of enrollment: 2001 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival.Amanda Klein, Luke Kosinski, Alexandre Loupy, Eric Frey, Ilkka Helanterä, Herwig-Ulf Meier-Kriesche, William E Fitzsimmons, , Mark Stegall, Kenneth Newell, Roslyn B Ma...> ;American Journal of Transplantation. 2024 Apr 18
- B Cell-mediated Immune Regulation and the Quest for Transplantation Tolerance.Baert, L., Mahmudul, H., Joo, H., Oh, S., Stegall, M.> ;Transplantation. 2024 Feb 23
- 1 citationsA Machine Learning-Driven Virtual Biopsy System For Kidney Transplant Patients.Yoo, D., Divard, G., Raynaud, M., Cohen, A., Mone, T., Rosenthal, J., Bentall, A., Stegall, M., Naesens, M., Zhang, H., Wang, C., Gueguen, J., Kamar, N., Bouquegneau, ...> ;Nature Communications. 2024 Jan 16
- Join now to see all
Journal Articles
- Long‐Term Outcomes of Eculizumab‐Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor‐Specific AntibodiesMatthew Everly, Lynn D Cornell, Carrie A Schinstock, Andrew J Bentall, Mark D Stegall, American journal of transplantation
Press Mentions
A Mayo Clinic AI Program Could Soon Be Part of Kidney Transplant CareApril 1st, 2023- Five Ways AI Promises to Transform Organ TransplantsMarch 21st, 2023
- Mayo Clinic Study Expands Criteria to Be a Living Kidney DonorJuly 14th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
